Search Results 901-910 of 19761 for Hepatitis+C
Do not use this medicine together with medicine to treat hepatitis C virus infection, including ombitasvir/paritaprevir/ritonavir, with or without dasabuvir ( ...
Lessons Shared from Transmission of Hepatitis C Infection to Patients · Rheumatoid Arthritis Patients Can Face Serious Lower Gastrointestinal Disease. Related ...
... hepatitis C; patients must have negative testing for HIV, hepatitis B virus (HBV), hepatitis C virus (HCV) within 4 weeks prior to randomization ...
Have active hepatitis B or hepatitis C defined as: o HBV: hepatitis B ... hepatitis B core antibody (HBc Ab) positive subjects; o HCV: HCV ribonucleic ...
A lab member is purifying an adenovirus vector for preclinical testing. They've also examined using this vaccine technology for cytomegalovirus, hepatitis C and ...
Participants have a known active Hepatitis B (defined as Hepatitis B surface antigen [HBsAg] reactive) or known active Hepatitis C virus (defined as HCV RNA [ ...
Known active hepatitis B or hepatitis C with abnormal liver function tests. Cardiac disease (history of and/or active disease) that would preclude the use ...
... hepatitis B virus (HBV), or hepatitis C virus (HCV). Patients who are seropositive because of hepatitis B virus vaccine are eligible. Participating Mayo ...
This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.
Chronic ongoing infectious diseases (except hepatitis B or hepatitis C) requiring treatment (excluding prophylactic treatment) at the time of enrollment or ≤ ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.